| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
231,140,000 |
| Market
Cap: |
20.31(B) |
| Last
Volume: |
15,310,387 |
Avg
Vol: |
5,089,776 |
| 52
Week Range: |
$87.86 - $87.86 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-14 |
2023-10-13 |
2023-04-14 |
2022-04-14 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Venbio Select Advisor Llc |
See Remarks |
– – • |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(26,250,000) |
0 |
|
- |
|
| Venbio Select Advisor Llc |
See Remarks |
– – • |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,516) |
0 |
|
- |
|
| Itri Lorettta M |
Chief Medical Officer |
• – – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,000) |
0 |
|
- |
|
| Baum Charles M |
Director |
– • – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,667) |
0 |
|
- |
|
| Islam Khalid |
Director |
– • – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,516) |
0 |
|
- |
|
| Hutt Peter Barton |
Director |
– • – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,516) |
0 |
|
- |
|
| Ball Bryan |
Chief Quality Officer |
• – – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
|
- |
|
| Duncan Barbara Gayle |
Director |
– • – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(49,244) |
0 |
|
- |
|
| Canute Scott A |
Director |
– • – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,516) |
0 |
|
- |
|
| Malik Usama |
Chief Fin. & Business Officer |
• – – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,856) |
0 |
|
- |
|
| Duncan Barbara Gayle |
Director |
– • – |
2020-09-14 |
4 |
OE |
$16.96 |
$42,400 |
D/D |
2,500 |
39,577 |
|
- |
|
| Duncan Barbara Gayle |
Director |
– • – |
2020-08-17 |
4 |
OE |
$16.96 |
$339,200 |
D/D |
20,000 |
37,077 |
|
- |
|
| Duncan Barbara Gayle |
Director |
– • – |
2020-08-12 |
4 |
OE |
$12.93 |
$220,806 |
D/D |
17,077 |
17,077 |
|
- |
|
| Canute Scott A |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
17,234 |
|
- |
|
| Islam Khalid |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
17,234 |
|
- |
|
| Baum Charles M |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
13,385 |
|
- |
|
| Hutt Peter Barton |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
17,234 |
|
- |
|
| Duncan Barbara Gayle |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
13,385 |
|
- |
|
| Azelby Robert |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
3,718 |
|
- |
|
| Venbio Select Advisor Llc |
See Remarks |
– • • |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
17,234 |
|
- |
|
| Aghazadeh Behzad |
Director |
– • – |
2020-05-01 |
4 |
B |
$28.50 |
$49,875,000 |
I/I |
1,750,000 |
26,250,000 |
2.1 |
39% |
|
| Semerjian Harout |
President and CEO |
• • – |
2020-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
50,075 |
50,075 |
|
- |
|
| Venbio Select Advisor Llc |
see remarks |
– • • |
2020-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| Aghazadeh Behzad |
Director |
– • – |
2019-12-05 |
4 |
B |
$17.50 |
$35,000,000 |
I/I |
2,000,000 |
24,500,000 |
2.1 |
- |
|
| Aghazadeh Behzad |
See Remarks |
– • • |
2019-10-03 |
4 |
B |
$14.10 |
$7,050,000 |
I/I |
500,000 |
22,500,000 |
2.25 |
- |
|
278 Records found
|
|
Page 1 of 12 |
|
|
